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T cell activation is predicated on the interaction
between the T cell receptor and peptide-major
histocompatibility (pMHC) ligands. The factors
that determine the stimulatory potency of a
pMHC molecule remain unclear. We describe
results showing that a peptide exhibiting many
hallmarks of a weak agonist stimulates T cells
to proliferate more than the wild-type agonist
ligand. An in silico approach suggested that
the inability to form the central supramolecular
activation cluster (cSMAC) could underlie the
increased proliferation. This conclusion was
supported by experiments that showed that en-
hancing cSMAC formation reduced stimulatory
capacity of the weak peptide. Our studies high-
light the fact that a complex interplay of factors
determines the quality of a T cell antigen.
INTRODUCTION
The activation of T cells is stimulated by the binding of the
T cell receptor (TCR) to its ligand, short peptides (p) bound
to major histocompatibility (MHC) gene products. Initially
it was thought that each TCR was specific for a single
pMHCmolecule, but it is now clear that a variety of related
peptides can stimulate signaling through a particular TCR.
The specific sequence of a peptide determines its stimu-
latory ability and the resulting functional outcome.
Altered peptide ligands (APLs), generated by mutating
residues of the wild-type agonist peptide, have been
used to investigate the role of antigen quality on T cell ac-
tivation as well as mechanisms underlying TCR signaling
(Evavold et al., 1993). APLs can have enhanced or re-
duced stimulatory ability compared to the wild-type (WT)agonist peptide. The stimulatory potency of a peptide
has been correlated with a variety of parameters that in-
clude the dissociation rate of the TCR-pMHC complex,
the ability to downregulate TCRs, the ability to form an im-
munological synapse (IS), and the ability to generate fully
phosphorylated TCR-z chains (Bachmann et al., 1997;
Grakoui et al., 1999; Itoh et al., 1999; Kersh et al.,
1998a; Madrenas et al., 1995; Sloan-Lancaster et al.,
1994; Valitutti et al., 1995). The importance of the density
of antigenic pMHC molecules expressed on an APC has
also been noted (Gonzalez et al., 2005). How each of these
parameters is linked to biophysical features of the TCR-
pMHC interaction, stimulatory potency, and T cell signal-
ing is not clearly understood. In this paper, we try to parse
some of these connections by studying the relationship
between TCR-pMHC binding parameters, formation of
the IS, and T cell signaling and activation. For these stud-
ies, we stimulated AND TCR transgenic T cells (which rec-
ognize the moth cytochrome C (MCC) peptide presented
by I-Ek [Kaye et al., 1989]) with a series of APLs.
The IS refers to the spatially organized motif of mem-
brane proteins and cytosolic molecules that forms at the
junction between a T cell and an antigen-presenting cell
(APC) (Grakoui et al., 1999; Monks et al., 1998). In some
ISs, TCR and pMHC ligands are clustered in the center
of the contact area (a structure called the cSMAC). In spite
of numerous studies, the function of the cSMAC remains
elusive (e.g., Grakoui et al., 1999; Monks et al., 1998;
Campi et al., 2005; Lee et al., 2002, 2003; Lin et al.,
2005; Yokosuka et al., 2005).
We combined in vitro experiments with computational
studies to examine how TCR signaling may be influenced
by the biophysical parameters characterizing TCR-pMHC
binding and cSMAC formation. The computational results
show that, for pMHC ligands that bind the TCR with a suf-
ficiently long half-life, the primary function of the cSMAC is
to enhance TCR downregulation. One surprising con-
sequence of this effect is our finding that a weak pMHCImmunity 26, 345–355, March 2007 ª2007 Elsevier Inc. 345
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Signaling and Degradation in the cSMACFigure 1. Proliferative Response of AND
and 5C.C7 T Cells to WT and Altered
MCC Peptides
AND CD4+ T cells (A and B) and 5C.C7 CD4+ T
cells (C) were isolated from spleens of TCR
transgenic mice and stimulated with irradiated
B10.BR splenocytes and the indicated pep-
tides for 72 hr.
(A and C) The T cell proliferative response was
assessed by the incorporation of [3H]thymidine
added for the last 18 hr of the stimulation. A
representative of 10 individual experiments is
shown.
(B) AND T cells were CFSE labeled and stimu-
lated for 3 days with irradiated B10.BR spleno-
cytes loaded with 1 mM of the indicated pep-
tides. The T cell proliferative response was
assessed by CFSE dilution. A representative
of three individual experiments is shown.ligand that does not induce cSMAC formation results in
enhanced T cell proliferation compared to the wild-type
agonist. To prove that inability to induce cSMAC forma-
tion underlies the hyperproliferative response, we used
NKG2D, a receptor expressed on NK cells and some
CD8 T cells that can enhance cSMAC formation regard-
less of antigen quality (Markiewicz et al., 2005), and we
found that cSMAC formation inhibited the stimulatory ca-
pacity of the weak peptide agonist. Our computational
studies, however, also indicated that currently available
data cannot unequivocally conclude that the cSMAC
always inhibits T cell signaling and activation. Future
experimentation that could help resolve this issue are
suggested.
RESULTS
Identification of APLs for AND T Cells
To determine the relationship between antigen quality, IS
formation, and signaling, we used T cells from the AND
TCR transgenic mouse (Kaye et al., 1989). This TCR
recognizes theMCC88–103 peptide presented by I-Ek. Al-
though the stimulatory potency of a range of peptides ob-
tained bymutating residues of MCC is known for the other
cytochrome C TCR transgenic systems (Berg et al., 1989;
Lyons et al., 1996; Matsui et al., 1994; Reay et al., 1994;
Seder et al., 1992; Wulfing et al., 1997), APLs for AND
were less well defined. We therefore tested the ability of
several variants of the MCC peptide (including T102S,
K99A, Y97K, and T102L) to stimulate AND T cells. Two of
the peptides, Y97K and T102L, were previously known to
behave as null peptides for AND (Rogers et al., 1998).
First, we tested each peptide for its ability to induce T
cell proliferation. Naive T cells were stimulated with WT
or mutated MCC peptides, and T cell proliferative re-
sponses were measured by both [3H]thymidine uptake
and CFSE dilution. As expected, the two null peptides,
Y97K and T102L, did not induce any T cell proliferation346 Immunity 26, 345–355, March 2007 ª2007 Elsevier Inc.(Figure 1A, right). T102SandK99Aboth induced a stronger
T cell proliferative response than WT MCC peptide (Fig-
ure 1A, left). Results from CFSE-dilution experiments
were consistent with the thymidine incorporation data
(Figure 1B). We excluded the possibility that these differ-
ences were related to differences in activation-induced
cell death by measuring the percentages of live and
dead cells as well as by staining with annexin V (see
Figure S1 in the Supplemental Data available online).
These results suggest that both the K99A and T102S pep-
tides function as strong agonists.
We confirmed the identity of the peptides by assessing
the proliferative response of T cells to these same pep-
tides in another MCC-specific TCR transgenic model,
the 5C.C7 TCR (Seder et al., 1992). As expected, T102S
and K99A behaved as a weak agonist and a null peptide,
respectively, for 5C.C7 T cells (Figure 1C; Lyons et al.,
1996; Reay et al., 1994; Wulfing et al., 1997). Thus,
T102S and K99A peptides induce amore robust T cell pro-
liferative response than does the WT MCC peptide.
Determining Dissociation Kinetics and Relative
Affinities of WT, K99A, and T102S MCC Peptides
To determine the relative affinities of MCC, K99A, and
T102S for the AND TCR, we generated I-Ek tetramers
with each of the peptides and analyzed the equilibrium tet-
ramer staining of AND T cells by flow cytometry. Although
WT and T102S showed comparable tetramer binding at
the same dose, the amount of K99A tetramer staining of
AND T cells was much lower (Figure 2A). This suggested
that I-Ek-K99A has a lower relative affinity for the AND
TCR compared to the WT and T102S-loaded I-Ek com-
plexes.
Because differences in affinity for the TCR are often re-
lated to the off rates characterizing TCR-pMHC binding,
a tetramer decay assay was performed to determine the
relative off rates for MCC, K99A, and T102S. AND T cells
were incubated with the three tetramers, and tetramer
Immunity
Signaling and Degradation in the cSMACFigure 2. Staining of AND Cells with I-Ek Tetramers Presenting MCC and Its APLs
Naive CD4+ AND T cells were stained with the indicated tetramers for 3 hr at 4C (in azide-containing buffer) and with anti-CD8-FITC and anti-B220-
CyChrome during the last 30 min, and washed 3 times in ice-cold FACS buffer.
(A) Samples were immediately analyzed by flow cytometry.
(B) Samples were resuspended in FACS buffer with 100 mg/ml of 14.4.4 antibody and incubated at 4C. At indicated time points, aliquots were taken
and analyzed by flow cytometry for tetramer staining. Gate was set on FS/SS bright, CD8 and B220 cells. A representative of three independent
experiments is show.disassociation wasmonitored by flow cytometry over 2 hr.
The T102S and K99A tetramers disassociatedmuch faster
than the tetramers containing the WT peptide (Figure 2B).
Thus, these results suggest that complexes of T102S and
K99A pMHC with the AND TCR have a shorter apparent
half-life compared to theWTMCC peptide. In addition, al-
though we do not have a measurement of the on rate,
combining the relative affinity measurements with the re-
sults of the tetramer decay experiments suggests that
T102S binds the AND TCR with a larger on rate compared
to MCC.
TCR Downregulation and Degradation
The paradoxical finding that the T102S and K99A peptides
have faster off rates but stimulate a stronger proliferative
response led us to examine other measures of agonist
quality, such as the ability to induce TCR downregulation
and degradation (Bachmann et al., 1997; Itoh et al., 1999;
Valitutti et al., 1995). I-Ek-expressing CH27 cells were
loaded with a range of peptide concentrations and incu-
bated with T cells, and TCR downregulation was assessed
by flow cytometry. The WT and T102S peptides both in-
duced a dose-dependent downregulation of the TCR (Fig-
ure 3A). In contrast, K99A induced low downregulation,
and the Y97K and T102L peptides induced essentially
none (Figure 3A). Consistent with the idea that TCR down-
regulation is due to degradation, immunoblotting for TCR-
z chains showed that theWT and T102S peptides induced
markedly greater TCR degradation compared to the K99A
peptide (Figure 3B). Thus, although K99A induces a strong
T cell proliferative response, surprisingly, it induces poor
TCR downregulation and degradation like a weak agonist.
Antigen-Induced IS and cSMAC Formation
We next evaluated the ability of these peptides to induce
conjugate formation, IS formation, and cSMAC formation.
To assess conjugate formation, T cells and peptide-
loaded CH27 cells were labeled with two different coloreddyes, incubated together for 30 min, and quantitated by
flow cytometry. Conjugate formation between T cells
and APCs loaded with T102S, K99A, and WT MCC was
comparable and higher than conjugate formation with
APCs without peptide or loaded with a null peptide
(Figure 4A).
To assess IS and cSMAC formation in T cell-APC con-
jugates, AND T cells were transduced with a retrovirus
encoding TCR-z-GFP (Krummel et al., 2000) or doubly
transduced with retroviruses encoding CD11a-YFP and
CD28-CFP. After sorting, cells were incubated with
APCs preloaded with peptides, and conjugates were fixed
and analyzed for IS and cSMAC formation. Conjugates
were scored as having formed an IS if the mean fluores-
cence of the cSMAC marker, TCR-z, or CD28 at the con-
tact site was at least two times higher than the mean fluo-
rescence of the rest of the T cell membrane (Figure 4B and
Figure S2). Conjugates were scored as cSMAC positive if
there was an area of the contact site, not bigger than one-
third of the contact site, that had at least a two-fold enrich-
ment of TCR-z or CD28 (Figure 4B and Figure S2). In the
doubly transduced cells, we also confirmed that when
the cSMAC formed, CD28 accumulated in the center
and lacked the pSMACmarker, CD11a (Figure S2). Finally,
conjugates with no obvious TCR-z or CD28 accumulation
at the contact site were scored as negative (Figure 4B and
Figure S2).
The percentage of IS-positive conjugates was highest
for the T102S peptide, followed by the WT peptide, and
then by the K99A peptide (Figure 4C). Scoring the conju-
gates for cSMAC formation revealed a similar pattern
with cSMACs forming most readily with T102S, followed
byMCC, and then by K99A (Figure 4D and Figure S2A). Fi-
nally, the reduced ability of K99A to form a mature IS was
also seen when T cells were incubated on lipid bilayers
(Figure S3).Taken together, our results suggest that ability
to efficiently form cSMACs does not always correlate with
the stimulatory capacity of the peptide.Immunity 26, 345–355, March 2007 ª2007 Elsevier Inc. 347
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Signaling and Degradation in the cSMACFull and Partial TCR-z Phosphorylation
Another indicator of agonist quality is the ratio of fully (p23)
to partially (p21) phosphorylated TCR-z chains (Madrenas
et al., 1995; Sloan-Lancaster et al., 1994). Stimulation with
stronger agonists is thought to lead to a greater proportion
of fully phosphorylated receptors and is reflected in the ra-
tio of p23/p21 TCR-z phosphorylated forms. T cells were
stimulated with APCs loaded with the K99A, T102S, and
WT MCC peptides. Compared to stimulation with the
WT MCC peptide, both T102S and K99A showed lower
p23/p21 ratios (Figure 5A).
The time course of TCR-z phosphorylation over 1 hr re-
vealed differences in the kinetics of phosphorylation. Al-
though the WT MCC peptide induced a fast increase in
TCR-zphosphorylation that attenuated rapidly (Figure 5B),
stimulation with both K99A and T102S was prolonged and
detectable even after 1 hr of stimulation (Figure 5A). Sim-
ilar results were obtained when lysates were stained for
activated ERK (Figure S4). The prolonged kinetics of sig-
naling was specific for the peptide, as indicated by the
fact that it was detectable even with 1% peptide loaded
Figure 3. TCR Downregulation and Degradation in AND T
Cells Stimulated with WT and APLs for MCC 88–103 Peptide
(A) CD4+ T cells were purified from AND TCR tgmice spleens and stim-
ulated for 3 hr with CH27 cells loaded with increasing amounts of the
indicated peptides. Upon stimulation, cell conjugates were disrupted
by trypsin-EDTA treatment and cells were stained with anti-Vb3 and
anti-CD4, washed, and analyzed by flow cytometry for surface TCR
expression. A representative of seven independent experiments is
shown.
(B) Rested ANDCD4+ T cells were pretreated for 45min with cyclohex-
amide and subsequently stimulated for 3 hr with CH27 cells loaded
with 30 mMof the indicated peptide. Upon stimulation, cells were lysed
and TCR-z expression was assessed by immunoblotting. A represen-
tative of three independent experiments is shown.348 Immunity 26, 345–355, March 2007 ª2007 Elsevier Inc.(data not shown). Lastly, the overall amount of z-phos-
phorylation was stronger after T102S- and K99A-stimula-
tion compared toWT peptide. Thus, although the p23/p21
ratio was consistent with the shorter apparent half lives of
the T102S and K99A complexes, the intensity of tyrosine
phosphorylation and the prolonged kinetics correlated
with the proliferative response.
Relationships between Half-Life of TCR-pMHC
Complexes, cSMAC Formation,
and Integrated Signal
These seemingly paradoxical results showing, for exam-
ple, that the K99A peptide does not induce efficient
cSMAC formation but elicits a greater proliferative re-
sponse compared to the WT peptide (which induces
a cSMAC) suggested a complex interplay between com-
peting phenomena that was difficult to intuit. We therefore
undertook a computational study to gain further insights.
Because T cell activation requires prolonged signaling,
we assumed that the integrated amount of signaling
over time would correlate with proliferation. How the inte-
grated amount of signal depends upon the on and off rates
characterizing TCR-pMHC binding and cSMAC formation
was then analyzed. Because the role of the cSMAC in reg-
ulating TCR degradation is still unresolved, we examined
the consequences of two different hypotheses. In the first
hypothesis, no special assumption was made regarding
where receptor degradation can occur. Receptor-ligand
binding, downstream signaling reactions, and receptor
degradation were allowed to occur wherever the appropri-
ate molecules mediating specific chemical reactions en-
countered each other. In the second hypothesis, as per
suggestions in the literature (Campi et al., 2005; Yokosuka
et al., 2005), it was a priori assumed that receptor degra-
dation could occur only in the cSMAC.
Computational investigation of either hypothesis re-
quires a model for TCR signaling. The TCR signaling
model that we studied (described in the Experimental Pro-
cedures and Figure S5) is a modification of our previous
model (Lee et al., 2003). In the current model, TCR degra-
dation is treatedmore realistically by incorporating ubiqui-
tination by allowing for the recruitment of the E3 ubiquitin
ligase, Cbl, to phosphorylated ZAP-70 and CD3z mole-
cules. These interactions resulted in ubiquitination, and
only ubiquitinated receptors were subject to degradation.
Thus, degradation is naturally linked to the level and
concentration of phosphorylated substrates. In the first
model, no restriction was imposed as to where Cbl could
interact with receptors. In the second hypothesis, it was
assumed that these processes can occur only in the
cSMAC.
Calculationswere first carried out to examine the effects
of koff and cSMAC formation on the integrated signal, fix-
ing the on rate for TCR-pMHC binding.We studied two sit-
uations, one where a cSMAC was allowed to form regard-
less of the value of koff, and the other where the cSMAC
never forms. Consider first representative data for the first
hypothesis where no special assumption wasmade about
where receptor degradation can occur (Figure 6A). These
Immunity
Signaling and Degradation in the cSMACFigure 4. Conjugate and Immunological
Synapses Formation Induced by WT,
K99A, and T102S MCC Peptides
(A) CD4+ AND T cells were labeled with CFSE
and incubated for 30 min with peptide-pulsed,
Cell Trace-calcein-labeled CH27 cells. Cells
were then gently washed and conjugate forma-
tion assessed by flow cytometry. The percent-
age of T cells forming conjugates is presented
as percentage of total T cells. A representative
of three independent experiments is shown.
(B–D) CD4+ AND T cells were retrovirally trans-
duced with GFP-TCR-z and sorted for GFP ex-
pression. T cells were incubated with CH27
cells pulsed with 30 mM of the indicated pep-
tide. After 30 min, cells were fixed, mounted
on poly-L-lysine-treated slides, and analyzed
by confocal microscopy. More than 100 indi-
vidual T cell-CH27 conjugates collected in
three independent experiments were assessed
for each tested peptide. Examples of how cell
conjugates were scored for TCR-z accumula-
tion at the contact site are shown in (B). The
percentages of T cells accumulating TCR-z at
the contact site (C) and forming cSMACs (D)
are presented as percentage of total conju-
gates analyzed. A representative of three inde-
pendent experiments is shown.results showed that, for ligands that bind the TCR with
a long half-life, cSMAC formation led to a reduced amount
of integrated signal. On the other hand, for ligands that
bind the TCR with a short half-life, cSMAC formation is
predicted to lead to an increase in the total integrated
signal.
Analyses of our results showed that, for ligands with
long half-lives (small koff), receptors are triggered effi-
ciently without need for clustering in the cSMAC (Fig-
ure S6A). However, we found that, for these ligands,
cSMAC formation increases the rate of degradation (Fig-
ure S7A). Our analysis showed that this is because con-
centrating receptors in one spatial location (cSMAC)
enhances the ability of Cbl to ubiquitinate substrates
(Figure S8). Thus, the lower total integrated signal seen
for strong ligands when cSMACs can form is explained
by increased receptor downregulation (Figure S7A).
At larger values of koff (half-life is short), this was re-
versed. Because weakly binding ligands did not trigger
TCR efficiently, clustering of receptors, ligands, and ki-
nases in the cSMAC aids in the generation of phosphory-
lated receptors and activated signaling intermediates be-
cause the enhanced concentration increased receptor
occupancy and rates of phosphorylation (Figure S6B).
For these qualities of ligand, the integrated signal was dis-
tinctly smaller when the cSMAC did not form (Figure S7B).
Because these ligands induce lower amounts of phos-
phorylation and p23/p21 ratio (data not shown), the effects
of cSMAC formation on signaling dominated over the ef-
fects of cSMAC formation on receptor downregulation.
Importantly, the two curves in Figure 6A (with and without
cSMAC formation) intersect at a particular value of koffwhere the advantages and disadvantages of cSMAC for-
mation are balanced.
A critical issue in the interpretation of these simulations
for the first hypothesis is the threshold value of koff re-
quired to stimulate cSMAC formation (Grakoui et al.,
1999; Sumen et al., 2004) and the relationship between
this threshold and the point at which the two integrated
signaling curves intersect. If the value of koff that triggers
cSMAC formation does not correspond to the intersection
point, the amount of integrated signal will exhibit a discon-
tinuous change when T cells are stimulated by a ligand
that is slightly weaker than that required for efficient
cSMAC formation. For example, if the threshold value of
koff that triggers cSMAC formation is higher (to the right)
than the intersection point, the amount of integrated signal
will precipitously decrease for a ligand that has a value
of koff just above this threshold required for forming
cSMACs. If the threshold value of koff that triggers cSMAC
formation is smaller (to the left) of the intersection point,
the amount of integrated signal will abruptly increase for
ligandswhose binding to TCR has a value of koff just above
this threshold. Our experimental results showing that
K99A elicits a stronger proliferative response than MCC,
but does not form cSMACs efficiently, suggests that, if
the first model is valid, the threshold for cSMAC formation
lies to the left of the intersection point for AND T cells. It
also suggests that if T cells stimulated by K99A could be
manipulated to efficiently form a cSMAC, the integrated
signal (i.e., stimulatory capacity) would be lower.
Calculations for the second hypothesis, where it is
assumed that receptor downregulation can occur only
in the cSMAC, are shown in Figure 6B. In contrast toImmunity 26, 345–355, March 2007 ª2007 Elsevier Inc. 349
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Signaling and Degradation in the cSMACFigure 6A, the curves with and without cSMAC formation
do not cross at any value of koff. In this model, cSMAC for-
mation is predicted to reduce the amount of integrated
signal for all antigen qualities. Thus, this hypothesis is
also consistent with our experimental data on K99A: it
suggests that the inability to form a cSMAC will enhance
stimulatory capacity regardless of TCR-pMHC off rate.
Differences between the results in Figures 6A and 6B sug-
gest a way to distinguish between the two hypotheses. For
example, if a sufficiently weak ligand that normally cannot
stimulate cSMAC formation could be coerced to form
a cSMAC and the stimulatory potency increased, then
the first hypothesis would be correct.
NKG2D-Mediated cSMAC Formation Reduces
the Proliferative Response to K99A
Previously, we showed that the engagement of NKG2D on
CD8+ T cells allows for antigen-independent formation of
the cSMAC (Markiewicz et al., 2005). We reasoned, there-
fore, that expressing NKG2D on AND T cells might induce
cSMAC formation and thereby enable us to test whether
the stimulatory potency of K99A would be reduced by
cSMAC formation. AND T cells were doubly transduced
with retroviruses containing cDNAs for NKG2D and its re-
quired signaling adapter, DAP10-YFP. NKG2D-positive
cells were conjugated with APCs expressing the NKG2D
Figure 5. Kinetics of TCR-z Phosphorylation in AND Cells
upon Stimulation with WT, K99A, and T102S MCC
Rested AND CD4+ T cells were stimulated with CH27 cells loaded with
10 mM of the indicated peptide for the indicated times. Upon stimula-
tion, cells were lysed, and TCR-z was immunoprecipitated, immuno-
blotted for tyrosine phosphorylation, and analyzed by densitometry.
(A) p23/p21 ratio after WT, K99A, and T102S MCC stimulation over
time.
(B) The anti-phospho-tyrosine western blots analyzed by densitome-
try. A representative of four independent experiments is shown.350 Immunity 26, 345–355, March 2007 ª2007 Elsevier Inc.ligand, Rae-13, preincubated with the K99A peptide. As
expected, NKG2D engagement strongly enhanced
cSMAC formation both in the presence and absence of
K99A peptide (Figures 7A–7C). Importantly, expression
of NKG2D significantly reduced the level of proliferation
induced by K99A (Figure 7D). This supports our prediction
Figure 6. Dependence of Integrated Signal on Antigen Quality
(A) Results for the first hypothesis described in the text. Data for calcu-
lations are compared for two cases, one where a cSMAC (red) is
allowed to form regardless of the value of koff and the other where
no cSMAC (blue) is ever present. For small values of koff, cSMAC
formation inhibited the total amount of integrated signal, whereas the
opposite was true for ligands that bind TCRweakly. These calculations
were carried out with a pMHC density of 1 molecule/(mm)2. Higher
pMHC densities (e.g., 10 molecules/(mm)2) did not change the qualita-
tive behavior (Figure S11). These calculations were carried out for
a value (Li et al., 2004) of kon equal to 2200 M
1 s1.
(B) Results for the second hypothesis described in the text. Integrated
signal from a model (red) where the cSMAC serves as a site for degra-
dation only is compared with the situation where there is no cSMAC
formation (blue). All parameters are the same as in (A). The signal is
always higher when there is no cSMAC formation and there is no
intersection point, as in (A).
Immunity
Signaling and Degradation in the cSMACFigure 7. Coerced cSMAC Formation In-
hibits the Proliferative Response of AND
T Cells to K99A
CD4+ AND T cells were retrovirally transduced
with DAP10-YFP and NKG2D and sorted for
YFP and NKG2D expression. T cells were incu-
bated, as indicated, with wt CH27 cells or
CH27 cells transduced with Rae-13, unpulsed
or pulsed with 20 mM of the indicated peptide.
After 30 min, cells were fixed, mounted on
poly-L-lysine-treated slides, and analyzed by
confocal microscopy. More than 50 individual
T cell-CH27 conjugates obtained in two inde-
pendent experiments were assessed.
(A) Examples of how cell conjugates were
scored for DAP10-YFP accumulation at the
contact site are shown.
(B and C) The percentages of T cells accumu-
lating DAP10 at the contact site (B) and forming
cSMACs (C) are presented as the percentage
of total conjugates analyzed. A representative
of two independent experiments is shown.
(D) NKG2D and DAP10-double positive AND T
cells (white bar) andWT AND T cells (grey bars)
were stimulated with mitomycin C-treated,
Rae-1e-expressing CH27 cells pulsed with
3 mM or 0.1 mM (data not shown) of the indi-
cated peptide. The T cell proliferative re-
sponses were assessed by the incorporation
of [3H]thymidine added for the last 18 hr of
the stimulation. A representative of two inde-
pendent experiments is shown.that the enhanced proliferation seenwith K99A is due to its
inability to form cSMACs.
Relationship between On Rate for TCR-pMHC
Binding, cSMAC Formation, and Integrated Signal
We next used our in silico model to explore how a higher
proliferative response could be induced by the T102S
peptide. Tetramer binding experiments suggested that
the T102S-MHC complex binds the AND TCR with both
a faster relative on and off rate compared to MCC. We
therefore used the model to compare the effects of differ-
ent on rates on the total integrated signal. An example of
one of our simulations (following the first hypothesis)
where the on rate was increased by a factor of 10 is shown
(Figure S9). When the off rate is small and cSMACs form,
changing the on rate by a factor of 10 had relatively little
effect on the integrated signal. This can be explained by
the fact that when the half-life is long, receptor occupancy
is largely limited by the availability of pMHC. Under these
conditions, enhancing the on rate 10-fold led to only
a10% change in receptor occupancy. The on rate, how-
ever, became important when the off rate was larger (half-
life becomes shorter). Under these conditions, pMHC
availability is not the limiting factor; increases in the on
rate resulted in increased receptor occupancy and in-
creased integrated signal.
These computational results can potentially explain why
the T102S peptide, which has a larger apparent off rate
and a larger apparent on rate, can stimulate a stronger
proliferative response than MCC. The similar affinities ofT102S with MCC suggest that the level of receptor occu-
pancy is similar. But the faster on rate and larger off rate
suggests that binding by T102S is much more dynamic
than MCC with much greater levels of receptor-ligand ex-
change. The concomitant increased ‘‘serial triggering’’
could explain the higher integrated signal.
DISCUSSION
How different parameters determine the ability of a pMHC
molecule to stimulate T cell activation remains unclear.
Many studies (Kalergis et al., 2001; Kersh et al., 1998b)
have suggested that the off rate characterizing the binding
of pMHC ligands to TCR correlates well with its ability to
stimulate T cell activation. However, several anomalies
have been reported that raise questions about whether
this is the only measure of antigen quality. Thus, other
parameters and phenomena such as the change in heat
capacity upon receptor-ligand binding (Krogsgaard
et al., 2003; Qi et al., 2006), serial triggering, synergy be-
tween endogenous and agonist ligands (Wulfing et al.,
2002; Krogsgaard et al., 2005; Li et al., 2004), and costi-
mulatory interactions (Markiewicz et al., 2005; Purtic
et al., 2005; Wulfing et al., 2002) have been implicated in
modulating how T cells respond to antigen. Our studies
combined in vitro and in silico investigations to examine
the interplay between signaling, peptide quality, and
cSMAC formation.
Our results emphasize that the stimulatory potency of
a pMHC ligand depends upon many factors and thatImmunity 26, 345–355, March 2007 ª2007 Elsevier Inc. 351
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dramatic example of this is provided by our experimental
data for the stimulatory potency of the K99A peptide for
AND T cells. This ligand binds the AND TCR with a larger
value of the off rate compared to the WT MCC and does
not induce cSMAC formation. Yet, it elicited a greater pro-
liferative response. This result raises the question as to
whether other APLs classified only by proliferation assays
as superagonistsmight actually beweaker binding ligands
that do not induce cSMAC formation resulting in a higher
total integrated signal.
Our results suggest that the on rate characterizing TCR-
pMHC binding may be important but only when the half-
life of the complex is relatively short. When the half-life is
long, receptor occupancy is limited by the availability of
pMHC molecules, not the on rate. But when half-life is
short, a faster on rate will strongly enhance receptor occu-
pancy. Note, however, that these results apply to in vitro
experiments where the agonist ligand density is relatively
high. In vivo, antigen is limiting, and in this circumstance
synergy between endogenous and agonist ligands could
be important for signal amplification (Krogsgaard et al.,
2005; Li et al., 2004); this could lead to complications
that we have not considered.
When pMHC density is high, as in our in vitro experi-
ments, endogenous ligands are not necessary for recep-
tor triggering. In this circumstance, competition between
serial triggering and kinetic proofreading is predicted to
lead to an optimal half-life; i.e., pMHC that bind TCR
with this half-life are most stimulatory. The AND TCR is
not a physiological TCR and selects poorly on the k hap-
lotype. This suggests that the half-life of the AND TCR
for MCC peptide bound to I-Ak might be higher than opti-
mal. Thus, it is perhaps not surprising that T102S, which
binds the AND TCR with a shorter half-life compared to
MCC, enhances signaling.
One idea emerging from our studies is that the depen-
dence of cSMAC formation on TCR-pMHC half-life can
modulate how the integrated amount of TCR signaling
(and proliferative response) varies with receptor-ligand
binding parameters. Our calculations showed that, for li-
gands that bind TCR sufficiently strongly, weaker ligands
that do not induce cSMAC formation should induce
greater proliferative responses. This explanation for our
experimental data on AND T cells stimulated by the
K99A peptide are clearly supported by our results showing
the reduced stimulatory potency of this peptide upon
forcing cSMAC formation by expression of NKG2D. The
results of this experiment are especially striking because
NKG2D is thought to function as a costimulator to en-
hance signaling through the TCR.
We should also note that the results of the experiment
with NKG2D are consistent with both hypotheses whose
consequences we examined by using in silico modeling.
If the half-life for TCR-pMHC complexes is relatively
long, a ligand that cannot induce cSMAC formation will re-
sult in a larger integrated signal. This result is also consis-
tent with our previously reported experimental results that
showed that disruption of cSMAC formation resulting from352 Immunity 26, 345–355, March 2007 ª2007 Elsevier Inc.CD2AP deficiency resulted in prolonged signaling and
a more robust response when T cells were stimulated by
a strong agonist (Lee et al., 2003).
Recent work that used single-molecule imaging of T
cells interacting with artificial lipid bilayers loaded with
strong agonists and inhibitors of actin polymerization
and antibodies that block TCR engagement suggest that
signaling occurs mainly at the periphery of the contact
area in microclusters (Campi et al., 2005; Mossman
et al., 2005; Varma et al., 2006; Yokosuka et al., 2005).
Consistent with this result, our computer simulations
showed that, for high-affinity agonists, TCRs are efficiently
triggered in the periphery without need for clustering of
molecules in the cSMAC. Our computational model, how-
ever, does not explicitly treat microclusters because it is
a coarse-grained model that describes species in terms
of concentrations. However, we expect the qualitative re-
sults reported by us to be similar if we were to carry out
a simulation where individual receptor-ligand interactions
and their clusters were treated explicitly. This is because,
for strong agonists, we find that receptor triggering occurs
efficiently in the pSMAC in our coarse-grained calcula-
tions just as is posited to occur in microclusters.
The paucity of phosphotyrosine staining in the cSMAC
when T cells are stimulated by strong agonists has been
interpreted to signify that the cSMAC functions only as
a site of degradation (Mossman et al., 2005; Campi et al,
2005). Our computational results suggest that these past
studies and the results reported by us in the present paper
cannot unequivocally reach this conclusion because the
situation could be different for weak ligands that are yet
to be studied.
The major difference between the two hypotheses that
we examined is manifested in the response to a peptide
with a much shorter half-life than any we have tested.
For peptides with very short half-lives, the first hypothesis
(wherein no assumption is made about where degradation
may occur) predicts that if cSMAC formation could occur,
it would result in enhanced recognition of weak peptides.
In contrast, the second hypothesis (where it is posited that
degradation can occur only in the cSMAC) predicts that
cSMAC formation will always weaken signaling. Our ef-
forts to distinguish between these two hypotheses in this
way are currently constrained by the fact that no adequate
weak peptides are known for the AND TCR system.
It could beargued that theweakpeptides thatwould dis-
tinguish between these twomodels are not physiologically
relevant, because they would probably be too weak to ac-
tivate T cells. However, it has recently become clear that
endogenous peptides that are unable to stimulate T cell
activation on their own are likely to play significant roles
in TCR triggering (Krogsgaard et al., 2005; Li et al., 2004;
Yachi et al., 2006). The presence or absence of cSMACs
could potentially determine the stimulatory capacity of
such endogenous peptides at late time points in T cell
signaling. This also raises important issues about in vivo
situations wheremixtures of both weak and strong ligands
are present. Furthermore, the function of the cSMAC for
less sensitive naive T cells requires careful examination.
Immunity
Signaling and Degradation in the cSMACOur understanding of the function of the cSMAC is still
evolving. We hope that continued synergy between mod-
eling and experiments will help unravel this enigma.
EXPERIMENTAL PROCEDURES
Mice
AND TCR transgenic mice (B6;SJL-Tg(TcrAND)53Hed/J) and B10.BR
mice (B10.BR-H2k H2-T18a/SgSnJ) were purchased from The Jackson
Laboratory. 5C.C7 TCR transgenic mice (5C.C7 TCRtg RAG-2/
H-2a) were obtained from Taconic Farms. Mice were maintained under
pathogen-free conditions in theWashington University animal facilities
in accordance with institutional guidelines.
MCC Peptides
Wild-type and mutated moth cytochrome C (MCC) peptides 88–103
were synthesized by standard F-moc chemistry. The peptides were
purified to homogeneity by reverse-phase HPLC, and their composi-
tion was confirmed by mass spectrometry and amino acid analysis
(Washington University Mass Spectrometry Facility, St. Louis, MO).
T Cell Purification
For purification of splenic T cells, splenocytes were depleted of CD8+,
MHC class II-positive, and immunoglobulin-positive cells by antibody-
mediated nanoparticle negative selection (EasySep CD4+ negative se-
lection cocktail, StemCell Technologies). The CD4+ T cells were used
immediately as naive T cells or stimulated for 4 days with irradiated
B10.BR splenocytes and MCC peptide, rested for 2 days, and then
used.
TCR Downregulation
AND T cells were stimulated for 3 hr, in a 1:1 ratio, with peptide pulsed
or unpulsed CH27 I-Ek cells. Upon stimulation, cells were pelleted and
treated with trypsin-EDTA to break cell conjugates, washed, and
labeled with FITC-conjugated anti-CD4 and PE-conjugated anti-Vb3
antibodies (BD PharMingen). Vb3 surface expression was assessed
by flow cytometry (FACScan, BD Biosciences) on CD4-positive gated
cells. Data was analyzed by WinMDI 2.8 software (http://facs.scripps.
edu/software.html) or CellQuest (BD PharMingen).
Cell Lysis, Immunoprecipitation, and Western Blotting
AND T cells were pretreated with cyclohexamide for 45 minutes and
stimulated with an equal number of unpulsed or peptide-pulsed
CH27 I-Ek cells. After stimulation, cells were lysed for 10 min on ice
in 1% NP-40-containing lysis buffer and cleared by centrifugation.
For TCR degradation assays, postnuclear supernatants were resolved
on SDS-PAGE under reducing conditions, transferred to nitrocellulose
membranes, and immunoblotted with an anti-TCR-z antiserum. For
TCR-z phosphorylation, postnuclear supernatants were immunopre-
cipitated with an anti-TCR-z antiserum, resolved on SDS-PAGE, trans-
ferred to nitrocellulose membranes, and immunoblotted with an anti-
phosphotyrosine antibody (clone 4G10; Upstate Biotechnology). Blots
were visualized with ECL Western blotting kit (Pierce). Densitometry
was performed with IPLab software (Scanalytics).
T Cell Proliferation Assays
Naive or rested CD4+ AND or 5C.C7 T cells were stimulated for 48 hr
with irradiated B10.BR cells and various amounts of peptides, pulsed
with 1 mCi of [3H]thymidine/well, harvested 16 h later, and scintillation
counted. Cells were labeled with CFSE, stimulated for 3 days with irra-
diated B10.BR splenocytes prepulsed with peptides, and assessed for
CFSE staining by flow cytometry.
Transfection and Retroviral Transduction
The Plat E ecotropic packaging cell line was transfected with a TCR-z-
GFP retroviral construct (kindly provided byM. Davis, Stanford Univer-
sity) or amixture of NKG2D and DAP10-YFP retroviral constructs. ANDT cells were stimulated with irradiated B10.BR splenocytes and 10 mM
MCC peptide. At 18 and 42 hr after stimulation, T cells were incubated
for 4 hr with the viral supernatants upon spinfection for 45 min in the
presence of Lipofectamine 2000 (Invitrogen). At day 4 after stimulation,
GFP-positive T cells were sorted with FACSVantage flow sorter (BD
Biosciences) at the Washington University Pathology Cell Sorting
Facility. After NKG2D/DAP10-YFP double transduction, cells were
stained with a PE-labeled anti-NKG2D antibody, and YFP-positive,
PE-positive cells were sorted and used for further experimentation.
T Cell-APC Conjugate Formation
T cells and APCs were labeled with CFSE and Cell Trace calcein red-
orange, AM (Molecular Probes), respectively, and incubated for 30min
to allow conjugate formation. Cells were then gently washed and con-
jugate formation was assessed by flow cytometry as the ratio of CFSE/
Cell Trace double-positive cells to total CFSE-positive cells. Data were
analyzed by WinMDI 2.8 software (http://facs.scripps.edu/software.
html) or CellQuest (BD PharMingen).
IS and cSMAC Formation
Sorted retrovirally transduced AND T cells were incubated with pep-
tide loaded or unloaded CH27 I-Ek cells for 30 min. Cells were then
fixed and mounted on coverslips, and confocal images were taken
with a Zeiss LSM510 confocal microscope. Unprocessed images
were scored by ImageJ software (NIH, Bethesda, MD, http://rsb.info.
nih.gov/ij/, 1997–2006), as described in the text.
Tetramer Production, Tetramer Staining, and Tetramer-Decay
Experiments
I-Ek-MCC tetramers (with WT, K99A, or T102S MCC) were generated
as described previously (Gutgemann et al., 1998). For equilibrium
staining, AND T cells were stained with I-Ek-MCC tetramers for 3 hr
at 10C, washed twice, resuspended in FACS buffer, and analyzed
by flow cytometry. For relative koff measurements, AND T cells were
stained for 3 hr at 4C, washed twice, resuspended in FACS buffer in
the presence of 100 mg/ml of 14.4.4 antibody, and incubated at 4C
to allow tetramer decay. At specific time points, cells were removed
and analyzed for staining by flow cytometry. A tetramer with an irrele-
vant peptide bound (Hb) was used as a negative control. Mean fluo-
rescence at each time point was calculated by subtracting the mean
fluorescence of the negative control and then normalizing to the fluo-
rescence at time zero.
The Computational Model
A continuum model that parallels and complements our previous sto-
chastic models (Lee et al., 2003) was developed. This enables us to
readily examine large systems under diverse conditions and exhaus-
tively examine the sensitivity of themodel to values of unknown param-
eters. However, stochastic models (Lee et al., 2003; Li et al., 2004) are
necessary if the copy number of certain species is very small. Because
most in vitro experiments are carried out with a rather high antigen
dose (e.g., concentration of agonist peptides loaded on supported
lipid bilayers is 1–100 molecules/mm2 [Grakoui et al., 1999]), use of
the continuum model is appropriate. Varying the densities of various
species led to qualitatively similar results over a range of values, and
the effects of fluctuations for low pMHC densities and small values
of the off rate were not large for the conditions of interest in this paper
(Supplemental Data and Figure S10).
In the model, the membrane-associated and cytosolic molecules
undergo biochemical reactions according to the signaling cascade
shown in Figure S5. As described in the text, receptor degradation is
treated more accurately with incorporation of ubiquitination. Some de-
tails found not to affect qualitative results of interest in this paper were
not incorporated in the present study (feedback loops regulating Lck
activity [Altan-Bonnet and Germain, 2005; Stefanova et al., 2003]
and downstream signaling molecules [Ras, Rac, etc., that are down-
stream of ZAP70 activation]).Immunity 26, 345–355, March 2007 ª2007 Elsevier Inc. 353
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Signaling and Degradation in the cSMACcSMAC is modeled as described previously (Lee et al., 2003). We
link cSMAC formation to downstream signaling by turning on a poten-
tial field that acts on certain species and drives them to form a cSMAC
when activated ZAP70 exceeds a threshold. The spatially varying po-
tential field is a coarse-grained representation of forces (derivative of
a potential) that direct cSMAC formation. The magnitude of the poten-
tial is chosen so that a cSMAC forms in a few (5) minutes. The depth
and spatial variation of this potential field determine the rate of cSMAC
formation and the concentration of species therein.
The spatio-temporal distribution of each species varies because of
diffusion, biochemical reactions that are part of the signaling cascade,
and convective motion if a cSMAC is formed. The relevant equations
are provided in the Supplemental Data. The numerical methods used
to solve the large set of partial differential equations are provided in
the Supplemental Data, which also contains a list of parameters
used to carry out our calculations and a discussion of our relatively
extensive parameter sensitivity studies.
Supplemental Data
Supplemental Data include eleven figures, two tables, twomovies, and
Experimental Procedures and can be found with this article online at
http://www.immunity.com/cgi/content/full/26/3/345/DC1/.
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